American Cures Act

Bill: 116-s-1250
Sponsor: full_name: Sen. Durbin, Richard J. [D-IL]
Introduced: 2019-04-30
Policy area: Health
Subjects: Appropriations

Budget process

Centers for Disease Control and Prevention (CDC)

Defense spending

Department of Defense

Department of Health and Human Services

Department of Veterans Affairs

Disability and paralysis

Executive agency funding and structure

Health programs administration and funding

Health technology, devices, supplies

Medical research

Military medicine

National Institutes of Health (NIH)

Research administration and funding

Veterans' medical care
Latest action: action_date: 2019-04-30
text: Read twice and referred to the Committee on the Budget. (text: CR S2521-2522)

Summaries:
action_date: 2019-04-30
action_desc: Introduced in Senate
text: <p><b>American Cures Act </b></p> <p>This bill requires certain adjustments to discretionary spending limits over FY2020-FY2024 to accommodate increases in appropriations for agencies that perform biomedical research. Adjustments are required for the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense health program, and the Department of Veterans Affairs medical and prosthetics research program. </p> <p>The bill also requires annual appropriations in FY2020-FY2024 for each of the programs and agencies referenced in this bill to be at least the amount appropriated for FY2019. </p> <p>The bill exempts appropriations provided pursuant to this bill from sequestration. Sequestration is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals. </p>

tv_txt: II 116th CONGRESS 1st Session S. 1250 IN THE SENATE OF THE UNITED STATES April 30, 2019 Mr. Durbin (for himself, Mr. Brown , Mr. Van Hollen , Mr. Cardin , Mr. Casey , Mr. Markey , Ms. Baldwin , Mr. Blumenthal , and Ms. Klobuchar ) introduced the following bill; which was read twice and referred to the Committee on the Budget A BILL To prioritize funding for an expanded and sustained national investment in biomedical research.

1. Short title This Act may be cited as the American Cures Act . 2. Cap adjustment (a) In general Section 251(b)(2) of the Balanced Budget and Emergency Deficit Control Act of 1985 ( 2 U.S.C. 901(b)(2) ) is amended— (1) by redesignating subparagraphs (D), (E), and (F) as subparagraphs (E), (F), and (G), respectively; and (2) by inserting after subparagraph (C), the following: (D) Biomedical research (i) National Institutes of Health If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the National Institutes of Health at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed— (I) for fiscal year 2020, $2,737,000,000 in additional new budget authority; (II) for fiscal year 2021, $5,666,000,000 in additional new budget authority; (III) for fiscal year 2022, $8,800,000,000 in additional new budget authority; (IV) for fiscal year 2023, $12,153,000,000 in additional new budget authority; and (V) for fiscal year 2024, $15,741,000,000 in additional new budget authority. (ii) Centers for Disease Control and Prevention If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Centers for Disease Control and Prevention at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed— (I) for fiscal year 2020, $511,000,000 in additional new budget authority; (II) for fiscal year 2021, $1,057,000,000 in additional new budget authority; (III) for fiscal year 2022, $1,642,000,000 in additional new budget authority; (IV) for fiscal year 2023, $2,268,000,000 in additional new budget authority; and (V) for fiscal year 2024, $2,938,000,000 in additional new budget authority. (iii) Department of Defense health program If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Department of Defense health program, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed— (I) for fiscal year 2020, $167,510,000 in additional new budget authority; (II) for fiscal year 2021, $346,745,700 in additional new budget authority; (III) for fiscal year 2022, $538,527,899 in additional new budget authority; (IV) for fiscal year 2023, $743,734,852 in additional new budget authority; and (V) for fiscal year 2024, $963,306,292 in additional new budget authority. (iv) Medical and prosthetics research program of the Department of Veterans Affairs If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the medical and prosthetics research program of the Department of Veterans Affairs, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed— (I) for fiscal year 2020, $54,530,000 in additional new budget authority; (II) for fiscal year 2021, $58,350,000 in additional new budget authority; (III) for fiscal year 2022, $62,440,000 in additional new budget authority; (IV) for fiscal year 2023, $66,810,000 in additional new budget authority; and (V) for fiscal year 2024, $71,490,000 in additional new budget authority. (v) Definitions As used in this subparagraph: (I) Additional new budget authority The term additional new budget authority means— (aa) with respect to the National Institutes of Health, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the National Institutes of Health; (bb) with respect to the Centers for Disease Control and Prevention, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Centers for Disease Control and Prevention; (cc) with respect to the Department of Defense health program, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Department of Defense health program; and (dd) with respect to the medical and prosthetics research program of the Department of Veterans Affairs, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the medical and prosthetics research program of the Department of Veterans Affairs. (II) Centers for Disease Control and Prevention The term Centers for Disease Control and Prevention means the appropriations accounts that support the various institutes, offices, and centers that make up the Centers for Disease Control and Prevention. (III) Department of Defense health program The term Department of Defense health program means the appropriations accounts that support the various institutes, offices, and centers that make up the Department of Defense health program. (IV) Medical and prosthetics research program of the Department of Veterans Affairs The term medical and prosthetics research program of the Department of Veterans Affairs means the appropriations accounts that support the various institutes, offices, and centers that make up the medical and prosthetics research program of the Department of Veterans Affairs. (V) National Institutes of Health The term National Institutes of Health means the appropriations accounts that support the various institutes, offices, and centers that make up the National Institutes of Health. . (b) Funding There are hereby authorized to be appropriated— (1) for the National Institutes of Health, the amounts provided for under clause (i) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year; (2) for the Secretary of Health and Human Services, acting through the Centers for Disease Control and Prevention, the amounts provided for under clause (ii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year; (3) for the Department of Defense health program, the amounts provided for under clause (iii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year; and (4) for the medical and prosthetics research program of the Department of Veterans Affairs, the amounts provided for under clause (iv) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year. (c) Minimum Continued Funding Requirement Amounts appropriated for each of the programs and agencies described in section 251(b)(2)(D) of the Balanced Budget and Emergency Deficit Control Act of 1985 (as added by subsection (a)) for each of fiscal years 2020 through 2024, and each subsequent fiscal year, shall not be less than the amounts appropriated for such programs and agencies for fiscal year 2019. (d) Exemption of certain appropriations from sequestration (1) In general Section 255(g)(1)(A) of the Balanced Budget and Emergency Deficit Control Act ( 2 U.S.C. 905(g)(1)(A) ) is amended by inserting after Advances to the Unemployment Trust Fund and Other Funds (16–0327–0–1–600). the following: Appropriations under the American Cures Act . . (2) Applicability The amendment made by this section shall apply to any sequestration order issued under the Balanced Budget and Emergency Deficit Control Act of 1985 ( 2 U.S.C. 900 et seq.) on or after the date of enactment of this Act.